T3 Companies, LLC

Position in ABVX — Abivax S.A.

CIK 2052441 NEW YORK, NY

Back to ABVX Full portfolio

Position in ABVX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,041,426

+$406,731 QoQ

Shares Held

7,815

+37.1% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

1.32%

of 13F equity value

Holder Rank

#167

of 302 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026

CallValue

$2,425,332

CallShares

18,200

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names. ABVX ranks #1 (39.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A. This page	7,815	$1,041,426
2	IFRX	InflaRx N.V.	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc.	18,900	$615,195
4	CLDX	Celldex Therapeutics, Inc.	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

All Filings in ABVX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,425,332	18,200	+38.9%	Call	Sole	2026-07-27
2026-06-30	$1,041,426	7,815	+37.1%	Shares	Sole	2026-07-27
2026-03-31	$634,695	5,700	—	Shares	Sole	2026-05-07
2026-03-31	$12,123	13,100	—	Call	Sole	2026-05-07
No filing history on record for this holder in this stock.